Evidence map›Paper›PMID 41146888›Full record

ArticleInternational journal of women's health2025

High-Risk HPV Persistence and Clearance Patterns Among Women in Ethiopia: A Longitudinal Study.

Brhanu Teka, Adamu Addissie, Adane Mihret, Muluken Gizaw, Welelta Shiferaw, Zewditu Chanyalew, Andreas M Kaufmann, Eva Johanna Kantelhardt, Tamrat Abebe

Abstract read
In one paragraph

Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Brhanu TekaDepartment of Microbiology, Immunology and Parasitology, School of Biomedicine and Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0002-0124-6008
Adamu AddissieGlobal Health Working Group, Martin-Luther-University, Halle-Wittenberg, Germany.
Adane MihretDepartment of Microbiology, Immunology and Parasitology, School of Biomedicine and Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0003-3183-4772
Muluken GizawGlobal Health Working Group, Martin-Luther-University, Halle-Wittenberg, Germany.
Welelta ShiferawDepartment of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Zewditu ChanyalewDepartment of Pathology, St. Paul Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Andreas M KaufmannDepartment of Gynecology, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-7732-3009
Eva Johanna KantelhardtGlobal Health Working Group, Martin-Luther-University, Halle-Wittenberg, Germany.ORCID 0000-0001-7935-719X
Tamrat AbebeDepartment of Microbiology, Immunology and Parasitology, School of Biomedicine and Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0002-6100-9303

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: High-risk human papillomavirus (hr-HPV) types are the primary cause of cervical and anogenital cancers. Understanding patterns of persistence, clearance, and re-infection is essential, as persistent infections contribute to precancerous and invasive lesions. This study evaluated hr-HPV infection dynamics and genotype specific outcomes over two years among Ethiopian women. Patients and Methods: A cohort of 893 women aged 30-49 years was followed for two years using self-collected samples for multiplexed hr-HPV genotyping by BSGP5+/6+ PCR. Women testing positive were re-evaluated at 6 and 24 months with HPV genotyping, Visual Inspection with Acetic Acid (VIA) and cytology. Persistent infection was defined as continuous HPV DNA presence over consecutive visits, while clearance indicated no detectable virus. Re-infection occurred if a cleared HPV type reappeared, or a new type was detected. Results: After six months, 26.3% had persistent infections, while 73.7% cleared the infection. After two years, 13.2% experienced persistence, and 86.8% cleared their infections. Among women who tested negative at baseline, 74 were re-tested and showed hr-HPV incidence of 4.05% after 24 months. Genotype persistence rates varied, with HPV68, 82, 53, 52, and 56 showing the highest persistence after six months. After 24 months, HPV59, 68, 66, 52, and 16 had the highest persistence. Additionally, 29.9% of women at six months had abnormal cytology, including Atypical squamous cells of undetermined significance (ASCUS) and High grade squamous intraepithelial lesion (HSIL), which was 10.3% of those tested. Conclusion: The findings show that most hr-HPV infections among rural Ethiopian women cleared within two years, with varying persistence and clearance rates across HPV types. This emphasizes the need for regular monitoring and targeted prevention in high HPV prevalence populations.

Indexed as

cervical cancerEthiopiahigh-risk genotypesHPVnatural historypersistence

Identifiers

PMID41146888
PMCPMC12554270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.